NCT06179810 is a NA clinical trial of Baduanjin exercise in Metabolic Syndrome, sponsored by Cairo University.

Who is sponsoring NCT06179810?

NCT06179810 is sponsored by Cairo University.

What drugs are being tested in NCT06179810?

Interventions in NCT06179810: Baduanjin exercise.

What condition does NCT06179810 study?

NCT06179810 studies Metabolic Syndrome.

Is NCT06179810 still recruiting?

NCT06179810 is currently status unknown. Last updated 22 December 2023.

Last reviewed 2023-12-22 · How we verify

NCT06179810

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Baduanjin Exercise on Metabolic Syndrome Patients

Status unknown NA Last updated 22 December 2023

What this trial tests

NA trial testing Baduanjin exercise in Metabolic Syndrome in 60 participants. Status unknown.

Timeline

15 May 2023

Primary endpoint
15 December 2023

15 December 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	15 May 2023
Primary completion	15 December 2023
Estimated completion	15 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

Baduanjin exercise

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →

Sponsor

Cairo University

Who can join

Adults 60 to 75, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pre/posttest randomized control trial design. In this study all patients will be randomly assigned into two groups (30 in each group) : * Group A will do baduanjin exercise in addition to traditional medical treatment. * Group B will take traditional medical treatment only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Baduanjin exercise

Trials testing the same drug.

NCT07482995 — Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults · NA · not yet recruiting
NCT07163676 — Is There a Response of Glaucoma to Baduanjin Exercise in Elders? · NA · recruiting
NCT06346379 — The Effect of Baduanjin on Physical Fitness and Bone Density in Maintenance Hemodialysis Patients · NA · unknown
NCT06314321 — The Effect of Baduanjin on Shoulder Function in Maintenance Hemodialysis Patients · NA · completed
NCT03229681 — Baduanjin Exercise for Patients With Chronic Heart Failure on Phase II Cardiac Rehabilitation · NA · unknown

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06179810 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 22 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06179810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing